Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placental and neonatal immunity study
NL-OMON44239Recruiting
- Sponsor
- Radboudumc
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of azathioprine (3 arms), sponsored by Radboudumc. Primary endpoints: Influence of immunosuppressive drugs on immune responses in placental, peripheral blood, and cord blood mononuclear cells and Neonatal immune response compared with adult immune response. Started Jan 2018; status: recruiting.
02
Drugs
azathioprine
Beyond the preview
Go deeper on NL-OMON44239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44239.